Pacific Channel is a venture development and investment company, specialising in technology and life science-based industries. It was formed to provide a channel to the resources of the USA; the largest market for biotechnology-based products.

Pacific Channel and its US affiliate The Channel Group, have direct experience in the formation, management and growth (including exits) of biotechnology companies worldwide. Pacific Channel provides an important global perspective and access to North American markets for portfolio and client companies.

Pacific Channel also offers access to an international network of associates and advisers with extensive life science industry experience.  Read about Our Affiliates

Pacific Channel’s mandate is to support new biotech companies in the emerging biotech markets in Australia and New Zealand; and to accelerate the growth and expansion of established companies into offshore markets, in particular the USA, where the greatest concentration of capital exists.

As emerging biotechnology centres, Australia and New Zealand are producing new biotechnology companies with significant potential backed by the region’s extensive science knowledge base and government support. Involvement of entrepreneurial sectors, efficient approval processes and reduced costs provide competitive opportunity in the international biotech marketplace.

The progress of these companies can be supported by Pacific Channel’s access to extensive international intellectual and financial capital.

Pacific Channel believes that, relative to geography and opportunities, world class science has no boundaries.

Find out about Our Team and their depth and breadth of academic experience and commercial expertise.